IBERE PHARMACEUTICALS Quarterly Liabilities in USD from Q4 2020 to Q3 2022

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary: Ibere Pharmaceuticals quarterly Liabilities history and growth rate from Q4 2020 to Q3 2022.
Ibere Pharmaceuticals Liabilities for the quarter ending September 30, 2022 was $5.95M, a 51.1% decline year-over-year.

Liabilities, Quarterly (USD)

Liabilities, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2022	$5.95M	-$6.21M	-51.1%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$6.17M	-$7.96M	-56.3%	Jun 30, 2022	10-Q	2022-08-12
Q1 2022	$7.6M	-$6.82M	-47.3%	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$11.5M	+$10.9M	+1656%	Dec 31, 2021	10-Q	2022-11-14
Q3 2021	$12.2M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$14.1M			Jun 30, 2021	10-Q	2021-08-16
Q1 2021	$14.4M			Mar 31, 2021	10-Q/A	2021-08-16
Q4 2020	$657K			Dec 31, 2020	10-K	2022-03-31

* An asterisk sign (*) next to the value indicates that the value is likely invalid.